Evidence suggests that G6PD, the rate-limiting enzyme of the oxPPP, is inhibited by p53, the most frequently mutated tumor suppressor in human tumors [44], and that p73, which is frequently overexpressed in human cancers, promotes cell proliferation by increasing G6PD expression [50,51]. Here, TP53 is linked to neoplasm.